Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Cardiff University · Medical Research Council · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
967
total citations
- FWCI
- 52.09
- Percentile
- 100%
- References
- 25
Citations per year
Authors
21Topics & keywords
Topics
Keywords
- Cetuximab
- Medicine
- KRAS
- Oxaliplatin
- Internal medicine
- Colorectal cancer
- Capecitabine
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.